ApprovalTrail

Ingredient

Tranexamic Acid

Products in Health Canada’s databases that list Tranexamic Acid as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.

Drug products
24
21 authorized now
Natural health products
0
0 active licences
Notices of Compliance
47
Products in all
24

Drug products

Authorized products first.

NameDINStatus
CYKLOKAPRON 100 MG/ML (100 MG)02064413Marketed
CYKLOKAPRON 500 MG (500 MG)02064405Marketed
GD-TRANEXAMIC ACID (500 MG)02409097Marketed
M-TRANEXAMIC ACID (500 MG)02549395Marketed
MAR-TRANEXAMIC ACID (500 MG)02496232Marketed
TRANEXAMIC ACID (500 MG)02519194Marketed
TRANEXAMIC ACID INJECTION (100 MG)02392763Marketed
TRANEXAMIC ACID INJECTION (100 MG)02466015Marketed
TRANEXAMIC ACID INJECTION (100 MG)02497328Marketed
TRANEXAMIC ACID INJECTION (100 MG)02531194Marketed
TRANEXAMIC ACID INJECTION (100 MG)02531208Marketed
TRANEXAMIC ACID INJECTION BP (100 MG)02246365Marketed
TRANEXAMIC ACID TABLETS (500 MG)02401231Marketed
TRANEXAMIC ACID INJECTION (100 MG)02454785Approved
TRANEXAMIC ACID INJECTION (100 MG)02484846Approved
TRANEXAMIC ACID INJECTION (100 MG)02484897Approved
TRANEXAMIC ACID INJECTION (100 MG)02531216Approved
TRANEXAMIC ACID INJECTION BP (100 MG)02386933Dormant
TRANEXAMIC ACID INJECTION BP (100 MG)02455900Approved
TRANEXAMIC ACID INJECTION, USP (500 MG)02505274Approved
TRANEXAMIC ACID INJECTION, USP (1000 MG)02505282Approved
ERFA-TRANEXAMIC (100 MG)02457431Cancelled Post Market
GD-TRANEXAMIC ACID (100 MG)02409089Cancelled Pre Market
LYSTEDA (650.0 MG)02401959Cancelled Pre Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.